株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

ヒトマイクロバイオームの世界市場 - 産業洞察、市場動向、見通し、市場機会の分析 2016年~2024年

Human Microbiome Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024

発行 Coherent Market Insights 商品コード 785783
出版日 ページ情報 英文 220 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.62円で換算しております。
Back to Top
ヒトマイクロバイオームの世界市場 - 産業洞察、市場動向、見通し、市場機会の分析 2016年~2024年 Human Microbiome Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024
出版日: 2019年01月24日 ページ情報: 英文 220 Pages
概要

ヒトマイクロバイオームは人の消化を助け、免疫システムを調整し、血液凝固に必要なビタミンK、ビタミンB、ビタミンB12などのビタミン生産を可能にするため、現代の医療において大きな役割を果たしています。クロストリディウム・ディフィシル感染症(CDI)の有病率の上昇がヒトマイクロバイオーム市場の成長を促進する主な要因となっています

当レポートでは、ヒトマイクロバイオームの世界市場を調査し、市場の概要、製品タイプ・合併症・用途・流通チャネル・地域別の市場規模の推移と予測、市場の成長要因および阻害要因の分析、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 調査目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場概要

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー
    • 市場スニペット:製品タイプ別
    • 市場スニペット:適応症別
    • 市場スニペット:用途別
    • 市場スニペット:流通チャネル別
    • 市場スニペット:地域別
  • コヒーレントオポチュニティマップ(COM)

第3章 市場力学、規制、動向分析

  • マーケットダイナミクス
    • 成長要因
    • 阻害要因
    • 市場機会
  • 市場動向
  • 影響分析
  • 主なハイライト
  • PEST分析
  • ファイブフォース分析
  • 合併と買収
  • 規制の枠組み
  • 疫学

第4章 世界のヒトマイクロバイオーム市場:製品タイプ別

  • イントロダクション
  • 食品
  • 診断機器/キット
  • 医薬品
  • その他

第5章 世界のヒトマイクロバイオーム市場:適応症別

  • イントロダクション
  • 消化器疾患
  • 代謝異常
  • 女性特有の疾患
  • その他

第6章 世界のヒトマイクロバイオーム市場:用途別

  • イントロダクション
  • 治療
  • 診断

第7章 世界のヒトマイクロバイオーム市場:流通経路別

  • イントロダクション
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第8章 世界のヒトマイクロバイオーム市場:地域別

  • イントロダクション
  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋地域
  • 中東
  • アフリカ

第9章 競争環境

  • ヒートマップ解析
  • 市場シェア分析
  • 企業プロファイル
    • Enterome Bioscience
    • ヤクルト本社
    • DuPont
    • AG Metabiomics Corporation
    • ViThera Pharmaceuticals
    • Second Genome Inc.
    • AOBiome LLC
    • Seres Therapeutics
    • uBiome, Inc.
    • Rebiotix, Inc.
    • Synthetic Biologics, Inc.
    • MicroBiome Therapeutics LLC
    • Vedanta BioSciences
    • Osel, Inc.
    • Merck & Co., Inc
  • アナリストの意見

第10章 セクション

  • 参考文献
  • 調査方法
  • Coherent Market Insightsについて
目次

Human microbiome plays a major role in modern healthcare, as they allow easy digestion of food, regulation of immune system, and production of vitamins such as Vitamin K, Vitamin B, and Vitamin B12 essential for blood coagulation. Human microbiomes boosts immunity, nutrition, and others.

Market Dynamics

Increasing prevalence of C. Difficile infection (CDI) is a major factor driving human microbiome market growth. In 2010, the American Society for Microbiology, study of CDI over a 13-year period in Quebec, Canada, reported an increase in incidence from 35.6 cases per 100,000 population in 1991 to 156.3 cases per 100,000 population in 2003. According to study published in Clinical Infectious Disease journal in 2015, about 25% to 33% of antibiotic-associated diarrhea and 90% of pseudomembranous enteritis are caused by CDI. Moreover, introduction of probiotic may induce change in intestinal microbiota and can stabilize microbial communities, which may prevent gut inflammation, propelling growth of the human microbiome market over the forecast period. For instance, in October 2018, BioGaia subsidiary MetaboGen introduced two new strains Faecalibacterium prausnitzii (DSM 32379) and Desulfovibrio piger (DSM 32187) for safety study. These strains are derived from human gut microbiome.

Key features of the study:

  • This report provides in-depth analysis of the human microbiome market and provides market size (US$ 46.913 million) and Compound Annual Growth Rate (CAGR 17.5 %) for the forecast period (2018 - 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global human microbiome market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Enterome Bioscience, Yakult Honsha Co., Ltd., DuPont, Metabiomics Corporation, ViThera Pharmaceuticals, Second Genome Inc., AOBiome LLC, Seres Therapeutics, uBiome, Inc., Rebiotix, Inc., Synthetic Biologics, Inc., MicroBiome Therapeutics LLC, Vedanta BioSciences, Osel, Inc., and Merck & Co., Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global human microbiome market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the human microbiome market

Detailed Segmentation:

  • Global Human Microbiome Market, By Product Type:
    • Foods
      • Probiotic
      • Prebiotic
      • Medical Food
    • Diagnostic Devices/Kits
    • Drugs
    • Others
  • Global Human Microbiome Market, By Application:
    • Therapeutics
    • Diagnostics
  • Global Human Microbiome Market, By Disease Indication:
    • Gastrointestinal Disorders
    • Metabolic Disorders
    • Women Health
    • Cancer
    • Others
  • Global Human Microbiome Market, By Distribution Channel:
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • Global Human Microbiome Market, By Geography:
    • North America
      • By Product Type:
      • Foods
      • Probiotic
      • Prebiotic
      • Medical Food
      • Diagnostic Devices/Kits
      • Drugs
      • Others
      • By Application:
      • Therapeutics
      • Diagnostics
      • By Disease Indication:
      • Gastrointestinal Disorders
      • Metabolic Disorders
      • Women Health
      • Cancer
      • Others
      • By Distribution Channel:
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Product Type:
      • Foods
      • Probiotic
      • Prebiotic
      • Medical Food
      • Diagnostic Devices/Kits
      • Drugs
      • Others
      • By Application:
      • Therapeutics
      • Diagnostics
      • By Disease Indication:
      • Gastrointestinal Disorders
      • Metabolic Disorders
      • Women Health
      • Cancer
      • Others
      • By Distribution Channel:
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Product Type:
      • Foods
      • Probiotic
      • Prebiotic
      • Medical Food
      • Diagnostic Devices/Kits
      • Drugs
      • Others
      • By Application:
      • Therapeutics
      • Diagnostics
      • By Disease Indication:
      • Gastrointestinal Disorders
      • Metabolic Disorders
      • Women Health
      • Cancer
      • Others
      • By Distribution Channel:
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Product Type:
      • Foods
      • Probiotic
      • Prebiotic
      • Medical Food
      • Diagnostic Devices/Kits
      • Drugs
      • Others
      • By Application:
      • Therapeutics
      • Diagnostics
      • By Disease Indication:
      • Gastrointestinal Disorders
      • Metabolic Disorders
      • Women Health
      • Cancer
      • Others
      • By Distribution Channel:
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Product Type:
      • Foods
      • Probiotic
      • Prebiotic
      • Medical Food
      • Diagnostic Devices/Kits
      • Drugs
      • Others
      • By Application:
      • Therapeutics
      • Diagnostics
      • By Disease Indication:
      • Gastrointestinal Disorders
      • Metabolic Disorders
      • Women Health
      • Cancer
      • Others
      • By Distribution Channel:
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Product Type:
      • Foods
      • Probiotic
      • Prebiotic
      • Medical Food
      • Diagnostic Devices/Kits
      • Drugs
      • Others
      • By Application:
      • Therapeutics
      • Diagnostics
      • By Disease Indication:
      • Gastrointestinal Disorders
      • Metabolic Disorders
      • Women Health
      • Cancer
      • Others
      • By Distribution Channel:
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
      • By Country:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Enterome Bioscience*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Yakult Honsha Co., Ltd.
    • DuPont
    • AG Metabiomics Corporation
    • ViThera Pharmaceuticals
    • Second Genome Inc.
    • AOBiome LLC
    • Seres Therapeutics
    • uBiome, Inc.
    • Rebiotix, Inc.
    • Synthetic Biologics, Inc
    • MicroBiome Therapeutics LLC
    • Vedanta BioSciences
    • Osel, Inc.
    • Merck & Co., Inc
  • "*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Disease Indication
    • Market Snippet, By Application
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Market Trends
  • Impact Analysis
  • Key Highlights
  • PEST Analysis
  • PORTER's Analysis
  • Mergers and Acquisitions
  • Regulatory Framework
  • Epidemiology

4. Global Human Microbiome Market, By Product Type, 2016 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Foods
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
    • Segment Trends
    • Probiotic
    • Prebiotic
    • Medical Food
  • Diagnostic Devices/Kits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

5. Global Human Microbiome Market, By Disease Indication, 2018 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Gastrointestinal Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Metabolic Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Women Health
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Mn)

6. Global Human Microbiome Market, By Application, 2018 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Therapeutics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

7. Global Human Microbiome Market, By Distribution Channel, 2018 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Hospital Pharmacy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Retail Pharmacy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Online Pharmacy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

8. Global Human Microbiome Market, By Region, 2018 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016- 2026, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2018 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2018 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
  • Middle East
    • Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

9. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
  • Company Profiles
    • Enterome Bioscience*
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Yakult Honsha Co., Ltd.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • DuPont
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AG Metabiomics Corporation
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • ViThera Pharmaceuticals
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Second Genome Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AOBiome LLC
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Seres Therapeutics
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • uBiome, Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Rebiotix, Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Synthetic Biologics, Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • MicroBiome Therapeutics LLC
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Vedanta BioSciences
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Osel, Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Merck & Co., Inc
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
Back to Top